We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Small Benchtop Analyzer Offers Large Menu of Chemical Tests

By LabMedica International staff writers
Posted on 24 Sep 2008
Print article
A new benchtop chemistry analyzer provides a menu of over 100 tests. With low operating costs, it is suitable as a backup analyzer for hospitals or as a primary analyzer for small hospitals and physician office laboratories where space is a limited.

Called the BioLis 24i, the analyzer can perform 400-test per hour and has a menu of over 100 chemistries. Requiring only 31 inches (approximately 75 cm) of bench space, the instrument's large menu includes comprehensive metabolic, basic, hepatic, renal, anemia, and lipid panel tests. It also tests for specific proteins including immunoglobulins, C3, C4, transferrin, haptoglobin, antistreptolysin (ASO), rheumatoid factor (RF), C-reactive protein (CRP), prealbumin, and Apo lipoprotein (APO) lipoproteins. In addition, the analyzer can perform diabetic screening tests and tests for therapeutic drugs and drugs of abuse.

The analyzer has permanent cuvettes and a distilled water system. A thorough 10-step cuvette wash station administers heated alkaline and acid washes before and after each run prevents carryover. Positive sample ID and elimination of instrument programming are achieved with bidirectional interface and barcoded primary tube sampling. A laboratory information system (LIS) interface into electronic medical records (EMR) is also easily achieved. Thirty-day onboard reagent stability and 14-day calibration stability make daily start up a matter of running quality control (QC).

BioLis 24i is a marketed by Carolina Chemistries (Los Angeles, CA, USA). The company's technical representatives and service engineers install the analyzer and provide training in its use. The BioLis 24i is installed with a water system and drain into a sink. Electrical requirement of 110 VAC allow it to be installed anywhere.

Related Links:
Carolina Chemistries


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.